Catalyst Wire Dossier Catalyst Wire Dossier

Efient

prasugrel · Substipharm
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Efient, covering 2025-11-13 to 2025-11-13. Get the full timeline:

Most recent: EMA Authorised: Efient (prasugrel) — Substipharm

See pricing